Risk for ESRD in type 1 diabetes remains high despite renoprotection. - Test2 - elhamkhani - TriplyDB

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

http://www.wikidata.org/entity/Q34695426

about

Kidney disease: new technologies translate mechanisms to cure Guidance cue netrin-1 and the regulation of inflammation in acute and chronic kidney disease RAGE and CYBA polymorphisms are associated with microalbuminuria and end-stage renal disease onset in a cohort of type 1 diabetes mellitus patients over a 20-year follow-up New susceptibility loci associated with kidney disease in type 1 diabetes.Alterations of urinary metabolite profile in model diabetic nephropathy.Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria.Role of podocyte B7-1 in diabetic nephropathy Effects of glucose and blood pressure control on diabetic kidney disease in old patients with type 2 diabetes Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes Renal outcomes in patients with type 1 diabetes and macroalbuminuria Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria.Urinary semaphorin 3A correlates with diabetic proteinuria and mediates diabetic nephropathy and associated inflammation in mice.Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study.Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy.Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.Deletion of UNC5B in Kidney Epithelium Exacerbates Diabetic Nephropathy in Mice Results of pancreas transplantation alone with special attention to native kidney function and proteinuria in type 1 diabetes patients.Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes Circulating TGF-β1-Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes.Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease Mass Spectrometry Imaging Reveals Elevated Glomerular ATP/AMP in Diabetes/obesity and Identifies Sphingomyelin as a Possible Mediator Incidence of end stage renal disease among type 1 diabetes: a nationwide cohort study in Taiwan.The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease.High risk of ESRD in type 1 diabetes: new strategies are needed to retard progressive renal function decline Serum concentration of cystatin C and risk of end-stage renal disease in diabetes.Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.Can we target tubular damage to prevent renal function decline in diabetes?Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy.Improved incidence of end-stage renal disease of type 1 diabetes in Japan, from a hospital-based survey.Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study Blockade of KCa3.1 ameliorates renal fibrosis through the TGF-β1/Smad pathway in diabetic mice Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease Risk for end-stage renal disease over 25 years in the population-based WESDR cohort.The genetics of diabetic nephropathy.Tubular injury marker netrin-1 is elevated early in experimental diabetes The timing of dialysis and kidney transplantation in type 1 diabetes.

P2860

Q26825227-55C303B1-A814-4F4A-983B-E2CF8E3F8DDB Q26851850-7233ED29-EB42-4AE5-A80E-5EC882323369 Q28270272-CAFA9E3F-3540-4240-AD96-59B0EAD18924 Q29417066-9BA09F5C-3894-4066-B305-610C5B19E598 Q30369623-5E051284-9BE1-4F37-A0C5-BF10AD117AD8 Q30371076-A8CBC54F-175B-4303-A168-D2C48C931657 Q33814864-1DB05872-ACD6-4A61-883C-34D8DCC84486 Q34012168-760D8AB6-2AEF-449F-94D6-2010C044EB18 Q34256592-089BB0F9-C844-407C-A87F-CBF3568C4726 Q34260018-7C9B5AA6-9623-48AC-91EA-F8ECE8F5E58C Q34260068-EA707E9C-B643-4F6E-9F8D-C1796C1968AF Q34568748-1433A6E9-55CE-4B3E-91FB-E4873135EE26 Q34587701-47EDAF46-7BAD-46FF-83C8-0A9514D0E01D Q34695419-947A5680-C3B6-49C7-9BEE-B05A3D7C96AE Q35029060-24E3A613-F3F8-4957-822D-8E1B05780E57 Q35196985-DBDC1489-7DBA-45BE-B7F2-216DE2007696 Q35630730-53DDC99A-2EC3-4DF0-8B8E-80FC9435D4E5 Q35638934-852F00D9-DAC1-4579-BC83-0FBD5C692A4B Q35758489-9B7C8D0D-D019-4189-A351-3BA64FC98D90 Q35817069-8BEF33E0-66F5-4596-8F13-6B6D6BEF7922 Q35973844-FB2EEBDB-60A4-4A61-B321-FA19B3C5B876 Q35995060-0FADA475-80E3-4C19-92E5-D2FA617C4A2F Q36056764-99A96CC6-08CC-461B-B445-46F7B0121D08 Q36154168-0CA9629D-1127-4C68-8189-823928F99B4E Q36183114-A56C4746-D8A6-4A72-AEC1-7230BC33B227 Q36328889-4A075CDE-E1C4-47F5-AF7A-B5A75E2F6172 Q36334563-DFF98586-7DD6-471F-AE87-7458D074E92A Q36624687-9552A821-A5A2-46B4-A22A-5EF1B21DAAED Q36677752-8B1ECDC9-03C9-487D-BF8F-A119EFC9A441 Q36782780-9CD392CC-FCE0-4845-AEF1-4C48A24747E1 Q36818854-5240ABC7-0867-4553-9ECE-69FB7B935FF2 Q36844894-BF0457F1-93D5-4A76-ABED-F493E7D2C42F Q36849190-CE66E412-8357-4DB0-B248-E60621072E8D Q36988877-3F390242-CB8D-4B79-8415-1393A3E89667 Q37030987-E0C227F9-9813-48A5-88C2-62573565FABF Q37260216-A3E74481-79B4-4BA2-9999-63886C8D32C4 Q37504054-AF4A0E50-C24D-4A9D-85B2-3B4E361CB09F Q37590421-C1F991EC-7A60-4C77-B050-9A38C2D40CED Q37727065-99B2FEE9-04A5-4069-B6F9-64CB42DC32E4 Q37975222-080A9BE0-5FC6-4BBA-976D-EBB584AA4A6E

P2860

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

http://www.wikidata.org/entity/Q34695426

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

@ast

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

@en

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

@nl

type

label

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

@ast

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

@en

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

@nl

prefLabel

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

@ast

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

@en

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

@nl

P1433

Q34695426-D93C81CE-A430-499B-9FD6-D49170C2B277

P1476

Q34695426-EBF7C490-9B64-4B8F-8395-0AC39BAD8E3F

P2093

Q34695426-3D584A04-C98C-45A7-8F75-69CA4118D85D

Q34695426-468245FE-674D-438D-991E-7CDE988430DC

Q34695426-7AFB1415-DA23-4214-AC51-A93E05CC5342

Q34695426-93F4BC9F-D76E-40CA-A6B9-4AFB58DC1A66

Q34695426-A5541D94-A7DC-4939-869C-5F4ECF07C4A3

Q34695426-A9C6E200-A099-45FC-80AD-BEF2223E6508

Q34695426-D329DC28-DA81-4A95-BF4D-7AA86DC04DD0

Q34695426-DB801198-AB97-4485-B98F-620E647AEA52

Q34695426-EE67B87F-413C-49E9-8113-16D4E95BAD09

P2860

Q34695426-0C7B4A4E-4E04-4B9A-B3C4-BC76DE3A4190

Q34695426-1BE952B5-D2B1-493A-910E-8FD2CF279644

Q34695426-1D0FC148-7258-4C55-9358-E9076689177D

Q34695426-2A161572-95F2-425C-8A74-B0D6020DD8AB

Q34695426-3F7E5B66-1787-4C21-BD6D-1156B787E91B

Q34695426-516C4D92-D5D2-4010-94EE-04CAC6594C63

Q34695426-59BCD019-800E-42D1-B98A-F57D65BAF106

Q34695426-6A0EB780-ED03-400F-AB48-DCC2DA9D0E6C

Q34695426-6C74EBC1-1CAD-43DB-A6DF-C8087ACF86F3

Q34695426-6D4711F5-FA55-4836-936F-D6DA6DB66050

P304

Q34695426-EAF6AC19-9DAF-48BF-96E2-27489B3F3827

P31

Q34695426-A458E12D-32C8-43CD-9B98-83BCF13988BD

P356

Q34695426-DF1EF3FD-5234-4524-8C2E-414436F120C5

P433

Q34695426-CC030203-4B50-406D-9207-6EC8A0E53238

P478

Q34695426-1A08FD68-406F-4B46-A24A-D735926333CB

P577

Q34695426-BA0D2BA9-2477-4240-9BAC-D05AE826F293

P698

Q34695426-38886861-EDC6-4FDA-8479-3BDCA64B189C

P921

Q34695426-D3B0E31A-28C5-407D-A2C8-D35930DF4365

P932

Q34695426-BA714C1C-F2B9-4059-AE16-CC850AB68D3E

P356

P1433

Journal of the American Society of Nephrology

P1476

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

@en

P2093

Adam M Smiles

http://www.w3.org/2001/XMLSchema#string

Andrzej S Krolewski

http://www.w3.org/2001/XMLSchema#string

Bijan Roshan

http://www.w3.org/2001/XMLSchema#string

Elizabeth T Rosolowsky

http://www.w3.org/2001/XMLSchema#string

James H Warram

http://www.w3.org/2001/XMLSchema#string

Jan Skupien

http://www.w3.org/2001/XMLSchema#string

John H Eckfeldt

http://www.w3.org/2001/XMLSchema#string

Monika Niewczas

http://www.w3.org/2001/XMLSchema#string

Robert Stanton

http://www.w3.org/2001/XMLSchema#string

P2860

Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study

Aliskiren and dual therapy in type 2 diabetes mellitus

Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus.

Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy.

Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.

Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.

Preemptive renal transplantation: why not?

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.

Protein kinase C-beta inhibition for diabetic kidney disease.

Mechanisms of kidney fibrosis and the role of antifibrotic therapies.

P304

545-553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2010040354

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21355053

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

3060448

http://www.w3.org/2001/XMLSchema#string